NCT00002388View on ClinicalTrials.gov

A Study of 1592U89 in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Abacavir sulfate

Trial Locations (3)

12208

Albany Med College / Albany Med Ctr Hosp, Albany

60201

Evanston Hosp / Clinical Pharmacology Unit, Evanston

02115

Fenway Community Health Ctr / Research Dept, Boston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Glaxo Wellcome

INDUSTRY

NCT00002388 - A Study of 1592U89 in HIV-Infected Patients | Biotech Hunter | Biotech Hunter